FMR LLC 13D and 13G filings for Yumanity Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-09 10:04 am Purchase |
2022-02-08 | 13G | Yumanity Therapeutics, Inc. YMTX |
FMR LLC | 220,893 14.999% |
10,139 (+4.81%) |
Filing |
| 2021-12-10 08:52 am Purchase |
2021-12-09 | 13G | Yumanity Therapeutics, Inc. YMTX |
FMR LLC | 210,754 14.311% |
130,040 (+161.11%) |
Filing |
| 2021-11-10 12:24 pm Sale |
2021-11-09 | 13G | Yumanity Therapeutics, Inc. YMTX |
FMR LLC | 80,714 5.482% |
-88,728 (-52.36%) |
Filing |
| 2021-01-11 10:51 am Purchase |
2021-01-08 | 13G | Yumanity Therapeutics, Inc. YMTX |
FMR LLC | 169,441 11.749% |
169,441 (New Position) |
Filing |